{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T13:25:04Z","timestamp":1789133104070,"version":"build-2803163510"},"reference-count":43,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jem-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Emergency Medicine"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.jemermed.2016.05.042","type":"journal-article","created":{"date-parts":[[2016,8,23]],"date-time":"2016-08-23T03:22:34Z","timestamp":1471922554000},"page":"370-381","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Emergency Medicine Management of Sickle Cell Disease Complications: An Evidence-Based Update"],"prefix":"10.1016","volume":"51","author":[{"given":"Erica","family":"Simon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brit","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Koyfman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jemermed.2016.05.042_bib1","series-title":"Sickle cell disease. First Consult Elsevier","author":"Lanzkron","year":"2010"},{"key":"10.1016\/j.jemermed.2016.05.042_bib2","series-title":"Tintinalli's Emergency Medicine: A Comprehensive Study Guide","article-title":"Sickle cell disease and other hereditary hemolytic anemias","author":"Williams-Johnson","year":"2016"},{"key":"10.1016\/j.jemermed.2016.05.042_bib3","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1001\/jama.2014.10517","article-title":"Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members","volume":"312","author":"Yawn","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.jemermed.2016.05.042_bib4","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1161\/STROKEAHA.108.189696","article-title":"Management of stroke in infants and children. American Heart Association: scientific statement","volume":"39","author":"Roach","year":"2008","journal-title":"Stroke"},{"key":"10.1016\/j.jemermed.2016.05.042_bib5","first-page":"288","article-title":"Cerebrovascular accidents in sickle cell disease: rates and risk factors","volume":"91","author":"Ohene-Frempong","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.jemermed.2016.05.042_bib6","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1586\/ehm.11.61","article-title":"The epidemiology, evaluation and treatment of stroke in adults with sickle cell disease","volume":"4","author":"Strouse","year":"2011","journal-title":"Expert Rev Hematol"},{"key":"10.1016\/j.jemermed.2016.05.042_bib7","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jpeds.2015.03.051","article-title":"The pediatric stroke code: early management of the child with stroke","volume":"167","author":"Elbers","year":"2015","journal-title":"J Pediatr"},{"key":"10.1016\/j.jemermed.2016.05.042_bib8","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1161\/STROKEAHA.110.604199","article-title":"Hemorrhagic transformation of childhood arterial ischemic stroke","volume":"42","author":"Beslow","year":"2011","journal-title":"Stroke"},{"key":"10.1016\/j.jemermed.2016.05.042_bib9","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1212\/WNL.0b013e3182896ffb","article-title":"Hypertension at time of diagnosis and long-term outcome after childhood ischemic stroke","volume":"80","author":"Brush","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.jemermed.2016.05.042_bib10","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1212\/WNL.0b013e318211c19e","article-title":"Nonconvulsive seizures are common in critically ill children","volume":"76","author":"Abend","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.jemermed.2016.05.042_bib11","series-title":"Textbook of Pediatric Intensive Care","first-page":"1395","article-title":"Hematologic disorders in the pediatric intensive care unit","author":"Eskenazi","year":"1997"},{"key":"10.1016\/j.jemermed.2016.05.042_bib12","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1097\/00044067-200205000-00003","article-title":"Sickle cell anemia in the pediatric intensive care unit: novel approaches for managing life-threatening complications","volume":"13","author":"Jenkins","year":"2002","journal-title":"AACN Clin Issues"},{"key":"10.1016\/j.jemermed.2016.05.042_bib13","series-title":"Sickle cell in the ICU. Critical Care Perspectives in the Emergency Room","year":"2015"},{"key":"10.1016\/j.jemermed.2016.05.042_bib14","first-page":"569","article-title":"Sickle cell disease in the ICU","volume":"21","author":"Cecchini","year":"2015","journal-title":"Curr Opin Crit Care"},{"key":"10.1016\/j.jemermed.2016.05.042_bib15","series-title":"Evidence-Based Management of Sickle Cell Disease","first-page":"31","article-title":"Managing acute complications of sickle cell disease","author":"Afenyi-Annan","year":"2014"},{"key":"10.1016\/j.jemermed.2016.05.042_bib16","series-title":"The management of sickle cell disease","year":"2002"},{"key":"10.1016\/j.jemermed.2016.05.042_bib17","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.emc.2014.04.011","article-title":"Sickle cell disease in the emergency department","volume":"32","author":"Lovett","year":"2014","journal-title":"Emerg Med Clin North Am"},{"key":"10.1016\/j.jemermed.2016.05.042_bib18","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1046\/j.1365-2141.2003.04193.x","article-title":"Guidelines for the management of the acute painful crisis in sickle cell disease","volume":"20","author":"Rees","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jemermed.2016.05.042_bib19","series-title":"Standards for the clinical care of adults with sickle cell disease in the UK","author":"Olujohungbe","year":"2008"},{"key":"10.1016\/j.jemermed.2016.05.042_bib20","unstructured":"NHS Sickle Cell and Thalassaemia Screening Programmes. Sickle cell disease in childhood: standards and guidelines for clinical care. Published 2010. Available at: http:\/\/sct.screening.nhs.uk. Accessed December 01, 2015."},{"key":"10.1016\/j.jemermed.2016.05.042_bib21","unstructured":"National Institute for Health and Care Excellence (NICE). Sickle cell acute painful episode: Management of an acute painful sickle\u00a0cell episode in hospital. NICE Clinical Guideline 143. http:\/\/guidance.nice.org.uk\/CG143. Accessed December 01, 2015."},{"key":"10.1016\/j.jemermed.2016.05.042_bib22","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/bjh.12879","article-title":"Management of the acute painful crisis in sickle cell disease\u2014a re-evaluation of the use of opioids in adult patients","volume":"166","author":"Telfer","year":"2014","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jemermed.2016.05.042_bib23","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/j.1553-2712.2012.01330.x","article-title":"Adult emergency department patients with sickle cell pain crisis: results from a quality improvement learning collaborative model to improve analgesic management","volume":"19","author":"Tanabe","year":"2012","journal-title":"Acad Emerg Med"},{"key":"10.1016\/j.jemermed.2016.05.042_bib24","doi-asserted-by":"crossref","first-page":"e1016","DOI":"10.1542\/peds.2014-3470","article-title":"Improving the management of vaso-occlusive episodes in the pediatric emergency department","volume":"136","author":"Kavanagh","year":"2015","journal-title":"Pediatrics"},{"key":"10.1016\/j.jemermed.2016.05.042_bib25","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jemermed.2006.07.022","article-title":"Impact of an emergency department pain management protocol on the visits by patients with sickle cell disease","volume":"32","author":"Givens","year":"2007","journal-title":"J Emerg Med"},{"key":"10.1016\/j.jemermed.2016.05.042_bib26","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1002\/ajh.20944","article-title":"Patient-controlled analgesia versus continuous infusion of morphine during vaso-occlusive crisis in sickle cell disease, a randomized controlled trial","volume":"82","author":"van Beers","year":"2007","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jemermed.2016.05.042_bib27","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1001\/archinte.1991.00400070131017","article-title":"Intermittent injection vs patient-controlled analgesia for sickle cell crisis pain. Comparison in patients in the emergency department","volume":"151","author":"Gonzalez","year":"1991","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jemermed.2016.05.042_bib28","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1177\/1535370216642048","article-title":"Minireview: prognostic factors and the response to hydroxyurea treatment in sickle cell disease","volume":"241","author":"Wang","year":"2016","journal-title":"Exp Biol Med"},{"key":"10.1016\/j.jemermed.2016.05.042_bib29","doi-asserted-by":"crossref","first-page":"4304","DOI":"10.1182\/blood-2012-03-419879","article-title":"Impact of hydroxyuria on clinical events in the BABY HUG trial","volume":"20","author":"Thornburg","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jemermed.2016.05.042_bib30","first-page":"1235","article-title":"Acute hepatic sequestration in sickle cell disease","volume":"96","author":"Norris","year":"2004","journal-title":"J Natl Med Assoc"},{"key":"10.1016\/j.jemermed.2016.05.042_bib31","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.cgh.2010.02.016","article-title":"Gastrointestinal and hepatic complications of sickle cell disease","volume":"8","author":"Ebert","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jemermed.2016.05.042_bib32","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/00005792-198509000-00007","article-title":"Liver involvement in sickle cell disease","volume":"64","author":"Johnson","year":"1985","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jemermed.2016.05.042_bib33","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1053\/jhep.2001.24114","article-title":"Sickle cell hepatopathy","volume":"33","author":"Banerjee","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.jemermed.2016.05.042_bib34","doi-asserted-by":"crossref","first-page":"679","DOI":"10.3949\/ccjm.82a.14029","article-title":"Genitourinary manifestations of sickle cell disease","volume":"82","author":"Gebreselassie","year":"2015","journal-title":"Cleve Clin J Med"},{"key":"10.1016\/j.jemermed.2016.05.042_bib35","first-page":"597","article-title":"Genitourinary manifestations of sickle cell disease","volume":"64","author":"De Gracia-Nieto","year":"2011","journal-title":"Arch Esp Urol"},{"key":"10.1016\/j.jemermed.2016.05.042_bib36","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S0022-5347(05)65841-7","article-title":"Genitourinary complications of sickle cell disease","volume":"166","author":"Bruno","year":"2001","journal-title":"J Urol"},{"key":"10.1016\/j.jemermed.2016.05.042_bib37","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1111\/bjh.12199","article-title":"How I manage priapism due to sickle cell disease","volume":"160","author":"Olujohungbe","year":"2013","journal-title":"Br J Haematol"},{"issue":"4 Pt 1","key":"10.1016\/j.jemermed.2016.05.042_bib38","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1097\/01.ju.0000087608.07371.ca","article-title":"American Urological Association guideline on the management of priapism","volume":"170","author":"Montague","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.jemermed.2016.05.042_bib39","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1111\/bjh.13526","article-title":"How we prevent and manage infection in sickle cell disease","volume":"170","author":"Sobota","year":"2015","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jemermed.2016.05.042_bib40","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1542\/peds.2009-1465","article-title":"Burden of influenza-related hospitalization among children with sickle cell disease","volume":"125","author":"Bundy","year":"2010","journal-title":"Pediatrics"},{"key":"10.1016\/j.jemermed.2016.05.042_bib41","series-title":"Influenza. Influenza antiviral medications: summary for clinicians","year":"2016"},{"key":"10.1016\/j.jemermed.2016.05.042_bib42","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/MPH.0000000000000070","article-title":"Predictors of bacteremia among children with sickle cell disease presenting with fever","volume":"36","author":"Savlov","year":"2014","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.jemermed.2016.05.042_bib43","first-page":"483","article-title":"Life-threatening complications in sickle cell disease","volume":"Vol. II","author":"Rogers","year":"1997"}],"container-title":["The Journal of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073646791630172X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073646791630172X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:35:34Z","timestamp":1760027734000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S073646791630172X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S073646791630172X"],"URL":"https:\/\/doi.org\/10.1016\/j.jemermed.2016.05.042","relation":{},"ISSN":["0736-4679"],"issn-type":[{"value":"0736-4679","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Emergency Medicine Management of Sickle Cell Disease Complications: An Evidence-Based Update","name":"articletitle","label":"Article Title"},{"value":"The Journal of Emergency Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jemermed.2016.05.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}